Opioid Abuse: Outpatient Risk Identification and Stratification

 

In the United States, the use and abuse of opioids has become an epidemic, costing the nation billions of dollars every year. While opioids can be a safe and effective method of pain management, they can also be highly addictive. The issue is compounded when physicians and other prescribers prescribe opioids to patients who are at a high risk of opioid misuse or abuse without first exploring other options. In this module, we will explore the risk factors and stratification of opioid misuse, as well as assessment tools and strategies to ensure safe and effective pain management for patients using opioid medications.

$19.95

Hours: 0.75
REL-PI-0-P4PC23

Certificates

Certificates provided by accrediting body (7 Match)

District of Columbia Board of Nursing

0.75 HOURS


DC-RN -- District of Columbia Board of Nursing Approved Continuing Education program (CE Provider #50-290).

Nurses will receive 0.75 contact hours for participating in this course.

American Nurses Credentialing Center

0.75 HOURS


Relias, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Nurses will receive 0.75 contact hours for participating in this course.

Georgia Board of Nursing

0.75 HOURS


Georgia Board of Nursing CE Provider #: 50-290

Nurses will receive 0.75 contact hours for participating in this course.

Accreditation Council for Continuing Medical Education

0.75 HOURS


Relias LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Relias LLC designates this enduring material activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

South Carolina Board of Nursing

0.75 HOURS


This program was approved by the South Carolina Board of Nursing Approved Continuing Education Program (CE provider #50-290) CE Broker Course # 20-[Custom_Code]

Florida Board of Medicine

0.75 HOURS


Florida Board of Medicine CE Provider #: 50-290

Florida Physician Assistants

0.75 HOURS


Course Details

Course Code: REL-PI-0-P4PC23
Hours: 0.75
Type: Online Course
Content Expiration Date: 8/31/2020
Learning Objectives:
Identify risk factors for opioid misuse.
Discuss risk factors for opioid misuse for specific strata of patients.
Utilize proper assessment tools for at-risk patients.

Outline:
Section 1: Introduction A. About This Course B. Learning Objectives Section 2: The Opioid Endemic A. Meet Josephine B. Statistics C. Misuse and Abuse D. Risk Factors and Identification E. Review F. Summary Section 3: Risk Stratification A. Risk Stratification B. Opioid Risk in Older Adults C. Opioid Risk in Adults D. Opioid Risk in Youth E. Review F. Summary Section 4: Risk Identification and Assessment A. Risk Assessment B. The SOAPP®-R C. The BPI D. Other Indicators E. Review F. Summary Section 5: Conclusion A. Summary B. Course Contributors C. Resources D. References E. Congratulations! F. Exam G. BrainSparks

Staff Writer: Adam Roesner, BSN
Adam Roesner, BSN has been working with various quality measures optimization since 2013. His experience in program management in both clinical and performance measures allows a unique perspective on the challenge faced by healthcare systems today. Adam has presented trainings on HCAHPS programs for sales forces and executive leadership alike, and has managed various skin health and HCAHPS educational programs and bundles for acute, post-acute, and IDN facilities. Disclosure: Adam Roesner, BSN has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.
Expert Reviewer: Jack M. Gorman, MD

Jack M. Gorman, M.D. co-founded Critica Inc, a non-profit corporation, with his daughter, Dr. Sara Gorman, in 2016 and is its President and Chair. Critica is devoted to fighting science denial and promoting the acceptance of science in health and safety decision-making.

Before founding Critica, Dr. Gorman was Chief Scientific Officer and Senior Vice-President of both Comprehensive NeuroScience Inc and Care Management Technologies Inc. Dr. Gorman is co-editor of the textbooks Treatments that Work, now in its fourth edition, and Comprehensive Textbook of AIDS Psychiatry, now in its second edition, and author of the popular book The Essential Guide to Psychiatric Drugs, which appeared in its fourth edition in 2007. With his daughter, Dr. Sara Gorman, he wrote Denying to the Grave, on the reasons behind denial of scientific medical evidence, published by Oxford University Press in 2016. It has been discussed in media throughout the world. His newest book, Neuroscience at the Intersection of Mind and Brain, was published in 2018.

Disclosure: Jack M. Gorman, MD has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.
Target Audience:
The target audience for this course is: entry level Nurses; entry level Physician Assistants; entry level Physicians; in the following settings: All Healthcare Settings.
Relias will be transparent in disclosing if any commercial support, sponsorship or co-providership is present prior to the learner completing the course.
Course Delivery Method and Format
Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
Accommodations
If you require special accommodations to complete this module, please contact Relias Customer Support here.